FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR A Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- --Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals today announced that the Food and Drug ... (more)
http://ift.tt/1sGvGam
http://ift.tt/1sGvGam
No comments:
Post a Comment